Cuu Long Pharmaceutical JSC
Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, nervous system, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. The company is also involved i… Read more
Market Cap & Net Worth: Cuu Long Pharmaceutical JSC (DCL)
Cuu Long Pharmaceutical JSC (VN:DCL) has a market capitalization of $21.29K (₫540.87 Million) as of March 19, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #43762 globally and #329 in its home market, demonstrating a 1.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cuu Long Pharmaceutical JSC's stock price ₫55800.00 by its total outstanding shares 9693 (9.69K).
Cuu Long Pharmaceutical JSC Market Cap History: 2015 to 2026
Cuu Long Pharmaceutical JSC's market capitalization history from 2015 to 2026. Data shows growth from $3.41K to $21.29K (20.60% CAGR).
Cuu Long Pharmaceutical JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cuu Long Pharmaceutical JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DCL by Market Capitalization
Companies near Cuu Long Pharmaceutical JSC in the global market cap rankings as of March 19, 2026.
Key companies related to Cuu Long Pharmaceutical JSC by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Cuu Long Pharmaceutical JSC Historical Marketcap From 2015 to 2026
Between 2015 and today, Cuu Long Pharmaceutical JSC's market cap moved from $3.41K to $ 21.29K, with a yearly change of 20.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫21.29K | +29.77% |
| 2025 | ₫16.40K | +60.75% |
| 2024 | ₫10.20K | +7.00% |
| 2023 | ₫9.54K | +2.04% |
| 2022 | ₫9.35K | -38.44% |
| 2021 | ₫15.18K | +57.94% |
| 2020 | ₫9.61K | -10.00% |
| 2019 | ₫10.68K | +199.47% |
| 2018 | ₫3.57K | -59.35% |
| 2017 | ₫8.77K | -1.71% |
| 2016 | ₫8.93K | +162.08% |
| 2015 | ₫3.41K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cuu Long Pharmaceutical JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.29K USD |
| MoneyControl | $21.29K USD |
| MarketWatch | $21.29K USD |
| marketcap.company | $21.29K USD |
| Reuters | $21.29K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.